 Pia Hauk
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis, Atopic | 9 | 2022 | 321 | 1.740 |
Why?
| | Enzyme-Linked Immunospot Assay | 2 | 2022 | 35 | 0.950 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 538 | 0.850 |
Why?
| | Common Variable Immunodeficiency | 1 | 2021 | 27 | 0.740 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2021 | 62 | 0.720 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2021 | 130 | 0.700 |
Why?
| | Pneumococcal Vaccines | 1 | 2021 | 139 | 0.680 |
Why?
| | Anti-Allergic Agents | 1 | 2020 | 45 | 0.650 |
Why?
| | B-Lymphocytes | 1 | 2022 | 823 | 0.550 |
Why?
| | Sleep Wake Disorders | 1 | 2020 | 249 | 0.530 |
Why?
| | Food Hypersensitivity | 2 | 2022 | 173 | 0.400 |
Why?
| | Asthma | 7 | 2010 | 2219 | 0.350 |
Why?
| | Superantigens | 5 | 2001 | 70 | 0.330 |
Why?
| | Polysaccharides, Bacterial | 1 | 2008 | 67 | 0.300 |
Why?
| | Receptors, Glucocorticoid | 4 | 2002 | 148 | 0.290 |
Why?
| | Quality of Life | 1 | 2020 | 2694 | 0.290 |
Why?
| | Respiratory Sounds | 1 | 2008 | 121 | 0.280 |
Why?
| | Insect Bites and Stings | 4 | 2002 | 11 | 0.280 |
Why?
| | Adrenal Cortex Hormones | 3 | 2007 | 519 | 0.250 |
Why?
| | Submandibular Gland | 1 | 2025 | 19 | 0.240 |
Why?
| | Interleukin-5 | 1 | 2025 | 45 | 0.240 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 26 | 0.240 |
Why?
| | Neutrophils | 2 | 2008 | 1195 | 0.230 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2008 | 627 | 0.230 |
Why?
| | Glucocorticoids | 5 | 2025 | 575 | 0.220 |
Why?
| | Dexamethasone | 6 | 2010 | 340 | 0.220 |
Why?
| | Hybridomas | 1 | 2002 | 234 | 0.200 |
Why?
| | Child, Preschool | 8 | 2022 | 10450 | 0.200 |
Why?
| | Infant | 4 | 2025 | 8992 | 0.190 |
Why?
| | Immunogenicity, Vaccine | 1 | 2021 | 27 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 92 | 0.180 |
Why?
| | Bees | 2 | 2002 | 18 | 0.170 |
Why?
| | Tacrolimus | 1 | 2001 | 140 | 0.170 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 764 | 0.170 |
Why?
| | Immunoglobulin Variable Region | 1 | 1999 | 79 | 0.160 |
Why?
| | Child | 11 | 2022 | 20805 | 0.160 |
Why?
| | Immunoglobulin G | 2 | 2022 | 846 | 0.160 |
Why?
| | Humans | 27 | 2025 | 129126 | 0.150 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 1999 | 334 | 0.150 |
Why?
| | Family | 1 | 2022 | 648 | 0.150 |
Why?
| | Drug Resistance | 4 | 2008 | 163 | 0.140 |
Why?
| | Bee Venoms | 4 | 2002 | 8 | 0.140 |
Why?
| | Hypersensitivity | 3 | 1999 | 250 | 0.140 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2017 | 20 | 0.140 |
Why?
| | Guanylate Cyclase | 1 | 2017 | 33 | 0.140 |
Why?
| | Germ-Line Mutation | 1 | 2017 | 138 | 0.130 |
Why?
| | Transcriptome | 1 | 2022 | 883 | 0.130 |
Why?
| | Pilot Projects | 1 | 2021 | 1567 | 0.130 |
Why?
| | Adrenergic Fibers | 1 | 1995 | 4 | 0.130 |
Why?
| | Catecholamines | 1 | 1995 | 97 | 0.120 |
Why?
| | Hymenoptera | 1 | 1995 | 4 | 0.120 |
Why?
| | Cell Proliferation | 1 | 2022 | 2347 | 0.120 |
Why?
| | Sympathetic Nervous System | 1 | 1995 | 184 | 0.110 |
Why?
| | Anaphylaxis | 1 | 1995 | 100 | 0.110 |
Why?
| | Sleep | 1 | 2020 | 676 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1999 | 847 | 0.100 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 89 | 0.100 |
Why?
| | Adolescent | 8 | 2025 | 20301 | 0.100 |
Why?
| | Risk Factors | 2 | 2022 | 9768 | 0.100 |
Why?
| | Bronchi | 2 | 2007 | 240 | 0.100 |
Why?
| | Female | 13 | 2022 | 68517 | 0.100 |
Why?
| | Parents | 1 | 2020 | 1308 | 0.090 |
Why?
| | Adult | 6 | 2021 | 35512 | 0.090 |
Why?
| | Prospective Studies | 1 | 2022 | 7079 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 330 | 0.090 |
Why?
| | Male | 13 | 2025 | 63201 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 317 | 0.080 |
Why?
| | Pregnancy | 1 | 2022 | 6375 | 0.080 |
Why?
| | Interleukin-10 | 2 | 2010 | 299 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2010 | 177 | 0.070 |
Why?
| | Prednisone | 1 | 2008 | 236 | 0.070 |
Why?
| | Macrophage Activation | 1 | 2008 | 187 | 0.070 |
Why?
| | Vitamin D | 1 | 2010 | 381 | 0.070 |
Why?
| | NF-kappa B | 2 | 2022 | 652 | 0.060 |
Why?
| | Bronchodilator Agents | 1 | 2007 | 245 | 0.060 |
Why?
| | Staphylococcus aureus | 2 | 2001 | 431 | 0.060 |
Why?
| | Skin | 2 | 2022 | 719 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2008 | 856 | 0.060 |
Why?
| | DNA Mutational Analysis | 2 | 2017 | 386 | 0.060 |
Why?
| | Skin Tests | 4 | 2002 | 100 | 0.060 |
Why?
| | Enterotoxins | 2 | 2000 | 89 | 0.050 |
Why?
| | Blotting, Western | 2 | 2002 | 1169 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2022 | 41 | 0.050 |
Why?
| | Dimerization | 1 | 2002 | 188 | 0.050 |
Why?
| | Transduction, Genetic | 1 | 2002 | 128 | 0.050 |
Why?
| | Hyperplasia | 1 | 2022 | 170 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2008 | 4010 | 0.050 |
Why?
| | Vesicular Transport Proteins | 1 | 2022 | 84 | 0.050 |
Why?
| | Bacterial Toxins | 2 | 1999 | 106 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 151 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2002 | 176 | 0.050 |
Why?
| | Allergens | 2 | 2022 | 383 | 0.050 |
Why?
| | Prevalence | 1 | 2008 | 2564 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 235 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2002 | 382 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2002 | 218 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2065 | 0.040 |
Why?
| | Cytokines | 1 | 2008 | 1987 | 0.040 |
Why?
| | Lymphocyte Activation | 2 | 2017 | 1098 | 0.040 |
Why?
| | Autophagy | 1 | 2022 | 267 | 0.040 |
Why?
| | Staphylococcus | 1 | 2000 | 74 | 0.040 |
Why?
| | Histamine Release | 1 | 1999 | 20 | 0.040 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 16 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 64 | 0.040 |
Why?
| | Desensitization, Immunologic | 2 | 2002 | 89 | 0.040 |
Why?
| | Bites and Stings | 1 | 1999 | 28 | 0.040 |
Why?
| | Skin Diseases, Bacterial | 1 | 1998 | 22 | 0.040 |
Why?
| | Cell Division | 1 | 2000 | 779 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 1998 | 120 | 0.040 |
Why?
| | T-Lymphocytes | 3 | 2017 | 1924 | 0.040 |
Why?
| | Psoriasis | 1 | 1998 | 92 | 0.040 |
Why?
| | Leadership | 1 | 2022 | 357 | 0.040 |
Why?
| | Mutation | 2 | 2022 | 3700 | 0.040 |
Why?
| | Immunization | 1 | 2000 | 412 | 0.040 |
Why?
| | Amino Acid Transport System ASC | 1 | 2017 | 12 | 0.040 |
Why?
| | Genes, Dominant | 1 | 2017 | 91 | 0.040 |
Why?
| | Immunoglobulin E | 2 | 1999 | 329 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 131 | 0.030 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2017 | 46 | 0.030 |
Why?
| | Glutamine | 1 | 2017 | 92 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 1999 | 410 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 115 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 690 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 366 | 0.030 |
Why?
| | Pedigree | 1 | 2017 | 486 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 147 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2022 | 1109 | 0.030 |
Why?
| | Receptors, Adrenergic | 1 | 1995 | 34 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1995 | 172 | 0.030 |
Why?
| | Arthropod Venoms | 1 | 1995 | 1 | 0.030 |
Why?
| | Epinephrine | 1 | 1995 | 138 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2002 | 1943 | 0.030 |
Why?
| | Norepinephrine | 1 | 1995 | 209 | 0.030 |
Why?
| | Animals | 5 | 2002 | 34600 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 380 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1999 | 1048 | 0.030 |
Why?
| | Dopamine | 1 | 1995 | 285 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2025 | 10226 | 0.020 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 26 | 0.020 |
Why?
| | Antibody Specificity | 2 | 2002 | 182 | 0.020 |
Why?
| | Cell Separation | 2 | 2001 | 313 | 0.020 |
Why?
| | Mice | 2 | 2002 | 16644 | 0.020 |
Why?
| | Time Factors | 2 | 1999 | 6518 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 1995 | 3033 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 25 | 0.020 |
Why?
| | Leukocyte Elastase | 1 | 2007 | 74 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2007 | 113 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1021 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2007 | 2676 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5407 | 0.020 |
Why?
| | Spirometry | 1 | 2007 | 251 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 757 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1995 | 4915 | 0.020 |
Why?
| | Monocytes | 1 | 2008 | 543 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2007 | 501 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2008 | 718 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 31079 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3383 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2002 | 57 | 0.010 |
Why?
| | Brain | 1 | 2014 | 2628 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1689 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2001 | 48 | 0.010 |
Why?
| | Macrophages | 1 | 2008 | 1466 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2001 | 258 | 0.010 |
Why?
| | Species Specificity | 1 | 2001 | 570 | 0.010 |
Why?
| | Isomerism | 1 | 1999 | 48 | 0.010 |
Why?
| | Cell Death | 1 | 2001 | 348 | 0.010 |
Why?
| | Bronchitis | 1 | 1999 | 42 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 896 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1999 | 374 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2001 | 1230 | 0.010 |
Why?
| | Reference Values | 1 | 1999 | 780 | 0.010 |
Why?
| | Airway Obstruction | 1 | 1999 | 149 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1462 | 0.010 |
Why?
| | Flow Cytometry | 1 | 1999 | 1142 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1707 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 1998 | 1671 | 0.000 |
Why?
|
|
Hauk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|